PCBP2 and neoplasm: In contrast, the combination of gemcitabine and the CCP/PCBP2 siRNA nanocomplex resulted in the greatest inhibition of collagen expression in the tumor, as it reduced collagen expression by 46.8% (Figure 8D, 8F).